Gregory Glover | Blog
February 9, 2022
A Washington D.C. circuit appellate court has ruled that FDA violated the Orphan Drug Act and unlawfully infringed on Catalyst Pharmaceuticals Inc.’s orphan drug exclusivity period when it approved another company’s drug - the same drug to be used in treating... More